Clinical Trials Directory

Trials / Sponsors / Nuwacell Biotechnologies Co., Ltd.

Nuwacell Biotechnologies Co., Ltd.

Industry · 9 registered clinical trials — 8 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Study of [89Zr]-Oxine-NCR100 Injection for the Cellular Distribution
KOA
Phase 12025-08-29
RecruitingA Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR201 in the Treatment of Subjects W
Parkinson Disease
Phase 12025-06-06
Not Yet RecruitingA Trial to Evaluate the Safety and Efficacy of NCR102 in Subjects With aGVHD
Acute Graft-versus-Host Disease
Phase 1 / Phase 22025-04-28
Not Yet RecruitingA Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR101 in the Treatment of Subjects W
Interstitial Lung Disease (ILD)
Phase 1 / Phase 22025-03-01
Not Yet RecruitingA Study of NCR100 Injection for the Treatment of Knee Osteoarthritis（ KOA）
Knee Osteoarthritis
Phase 1 / Phase 22025-02-20
Not Yet RecruitingA Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML)
Acute Myeloid Leukemia
Phase 12024-06-30
Not Yet RecruitingA Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor
Solid Tumor
N/A2024-02-01
UnknownA Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects Wi
Knee Osteoarthritis
Phase 12024-01-25
Not Yet RecruitingA Trial to Evaluate the Safety and Efficacy of NK Cells in Subjects With Myelodysplastic Syndromes
Relapsed / Refractory Myelodysplastic Syndromes
EARLY_Phase 12022-05-30